Form 4 for TWST Twist Bioscience Corp
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-12 · accession 0001062993-21-007502 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-13 | 2021-08-12 | TWST | CRANDELL KEITH | Dir | S - Sale | $106.93 | -1,412 | 486 | -74% | -$151.0K | |
| MI | 2021-08-13 | 2021-02-11+ | TWST | CRANDELL KEITH | Dir | J - Other | $0.00 | -978.0K | 0 | -100% | $0 |
| MI | 2021-08-13 | 2021-08-12 | TWST | CRANDELL KEITH | Dir | S - Sale | $107.01 | -43.6K | 78.6K | -36% | -$4.66M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-12 | S | D | 1,412 | $106.93 | 486 | D By Keith L. Crandell Trust | — | — | |
| 2 | Common | Common Stock | 2021-05-19 | J | A | 1 | $0.00 | 119,635 | I | — | — | |
| 3 | Common | Common Stock | 2021-08-12 | S | D | 2,555 | $107.56 | 76,047 | I By Arch Venture Fund VII, L.P. | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.405 to $107.70. (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F2) The shares were directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 4 | Common | Common Stock | 2021-02-11 | J | D | 286,480 | $0.00 | 440,354 | I By Keith L. Crandell Trust | — | — | |
| 5 | Common | Common Stock | 2021-02-11 | J | A | 14,560 | $0.00 | 97,252 | I By ARCH Venture Fund VIII Overage, L.P. | — | — | (F3) The shares were directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 6 | Common | Common Stock | 2021-02-11 | J | D | 113,520 | $0.00 | 174,584 | I By Keith L. Crandell Trust | — | — | |
| 7 | Common | Common Stock | 2021-02-11 | J | A | 1 | $0.00 | 97,253 | I By ARCH Venture Fund VII, L.P. | — | — | (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F2) The shares were directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 8 | Common | Common Stock | 2021-05-13 | J | D | 214,828 | $0.00 | 225,526 | I By Keith L. Crandell Trust | — | — | |
| 9 | Common | Common Stock | 2021-05-13 | J | A | 10,918 | $0.00 | 108,171 | I By ARCH Venture Fund VIII Overage, L.P. | — | — | (F3) The shares were directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 10 | Common | Common Stock | 2021-05-13 | J | D | 85,172 | $0.00 | 89,412 | I By Keith L. Crandell Trust | — | — | |
| 11 | Common | Common Stock | 2021-05-13 | J | A | 1 | $0.00 | 108,172 | I By ARCH Venture Fund VII, L.P. | — | — | (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F2) The shares were directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 12 | Common | Common Stock | 2021-05-19 | J | D | 225,526 | $0.00 | 0 | I By Keith L. Crandell Trust | — | — | |
| 13 | Common | Common Stock | 2021-05-19 | J | A | 11,462 | $0.00 | 119,634 | I By ARCH Venture Fund VIII Overage, L.P. | — | — | (F3) The shares were directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. (F4) Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |
| 14 | Common | Common Stock | 2021-05-19 | J | D | 89,412 | $0.00 | 0 | I By Keith L. Crandell Trust | — | — | |
| 15 | Common | Common Stock | 2021-08-12 | S | D | 41,033 | $106.98 | 78,602 | I By Keith L. Crandell Trust | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.39 to $107.37. The reporting person undertakes to provide to TWST, any security holder of TWST, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) and (7) to this Form 4. |